Partner or Supporter

Takeda Pharmaceutical Company Limited is a Japanese research-based global pharmaceutical company with a focus on prescription drugs.

CSL Behring is a biopharmaceutical company, manufacturing plasma-derived and recombinant therapeutic products and providing them to people in more than 100 countries. Its line of therapies includes products for the treatment of bleeding disorders such as hemophilia and von Willebrand Disease; primary immune deficiencies (PIDD) and hereditary angioedema, inherited respiratory disease; and neurological disorders in certain markets.

BioCryst Pharmaceuticals, Inc. is an American pharmaceutical company headquartered in Durham, North Carolina. The company is a late stage biotech company that focuses on oral drugs for rare and serious diseases. BioCryst's antiviral drug RAPIVAB was approved by FDA in Dec 2014. It has also been approved in Japan, Korea and China

CENTOGENE is one of the largest genetic biotech companies worldwide, the European market leader, and one of the global leaders in genetic diagnostic analyses of rare inherited diseases. Transforming global genetic data into medical decisions, that are focused on creating broader awareness for patients of all ethnicities around the world.

Moxie is a life science company focussed on improving the diagnostics and management of skin diseases and allergies. Our services and products (FricTest^®, AAS, AE-QoL and UCT) can help to improve personalized treatment and quality of life in patients with these conditions.